Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

COVID-19 Intelligence Report: Oncology

May 4, 2020

Title: Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak 

Publisher: Cancer Discovery

Publication Date: April 28, 2020

URL: https://cancerdiscovery.aacrjournals.org/content/candisc/early/2020/04/29/2159-8290.CD-20-0422.full.pdf     

Key Takeaway: COVID-19 patients with cancer had higher risks in all severe outcomes.

  • Patients with hematological cancer, lung cancer, or with metastatic cancer (stage IV) had the highest frequency of severe events.
  • Non-metastatic cancer patients experienced similar frequencies of severe conditions to those observed in patients without cancer.
  • Patients who received surgery had higher risks of having severe events, while patients with only radiotherapy did not demonstrate significant differences in severe events when compared to patients without cancer."

March 31, 2020

Title: Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal 

Publisher: Journal of the National Comprehensive Cancer Network (JNCCN)

Publication Date: March 20, 2020

URL:  https://jnccn.org/view/journals/jnccn/18/4/article-p366.xml

Key Takeaway: ​Article on the challenges of cancer treatment amidst the Covid-19 – experience from University of Washington Cancer Center.

The Himmelfarb Health Sciences Library
Questions? Ask us.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

The George Washington University